Manufacturer record
Jersy Pharma: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Jersy Pharma were declared Not of Standard Quality between June 2026 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: T3209, Mefenamic Acid and Paracetamol Tablets (exp Apr 2027). DTL, Bengaluru, Karnataka (state lab) found it not of standard quality: Assay for Mefenamic Acid. Listed in the September 2026 alert.
Records by type
2 records linked to Jersy Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Mefenamic Acid and Paracetamol Tablets | Batch T3209Mfg May 2024 · Exp Apr 2027 | Assay for Mefenamic AcidAssay | DTL, Bengaluru, KarnatakaState lab | Sep 2026 |
| Mefenamic Acid and Paracetamol Tablets | Batch T3209Mfg May 2024 · Exp Apr 2027 | Sample does not conform to Schedule V of the Drugs Rules, 1945 with respect to the Assay of Mefenamic Acid as specified in the laboratory protocol.Assay | RDTL ErnakulamState lab | Jun 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.